. Other more recent developments include photoacoustic imaging, which allows submillimeterresolution imaging in deep tissue 21 ; its primary limitations include the need for specialized instrumentation and the ability to image absorption contrast only. Window chamber models fill the niche of enabling high-resolution imaging using wide-field fluorescence, transmission or reflectance imaging, as well as any of the microscopy techniques described above. This technique is uniquely suited for applications requiring longitudinal, high-resolution imaging of dynamic processes.
Other imaging modalities that can retrieve functional information longitudinally include positron emission tomography, computed tomography, ultrasound and magnetic resonance imaging 22 . All of these methods are noninvasive but suffer from relatively high cost and low resolution. They also do not have the wide range of functional and genetic reporters available for optical techniques. Their primary advantage is the ability to image noninvasively in deep tissue; they can also provide more of a global view of the functional parameters that they are capable of reporting. Optical methods are best suited for high spatial and temporal resolution
In vivo optical molecular imaging and analysis in mice using dorsal window chamber models applied to hypoxia, vasculature and fluorescent reporters (micrometer and sub-second scales) imaging of localized treatment effects and microvascular dynamics-or as a low-cost means of monitoring a treatment effect repeatedly over time.
Experimental design Controls.
In applying such techniques to study cancer development and treatment response, appropriate controls are needed to separate treatment effects from tumor growth or normal variability over time. In such cases, a mock or vehicle-only treatment should be used as a control. In some cases, an internal control may be appropriate, such as when the relative change in a parameter immediately after a treatment is of most interest (for example, if one were interested in quantifying the acute change in oxygenation induced by breathing hyperoxic gas). A final control that may be appropriate, depending on the question of interest, is to use a normal window (with no tumor implanted) and/or examination of the normal tissue adjacent to the tumor. This enables separation of normal tissue response from pathological tumor response.
Calibration standards. This includes not only instrument response factors, which can be measured using an appropriate absorption or fluorescence standard, but also variability in tissue-specific factors over time. In in vivo fluorescence microscopy, for example, the signal measured is a function of not only the fluorophore distribution, but also of tissue absorption and scattering. When quantifying tumor GFP fluorescence, the signal could thus change over time as a result of tumor growth, alterations in absorption or scattering properties (e.g., changes in blood volume) or changes in GFP expression. Appropriate controls are critical in this situation, and one effective approach is to use ratiometric indicators, which are less sensitive to these parameters.
Quantification. Moreover, critical to this work is the development of quantitative experimental and analysis methods to fully characterize the range of optical sources of contrast available. Hyperspectral imaging enables acquisition of fluorescence emission or reflectance/transmission spectra on a pixel-by-pixel basis. We have used a liquid-crystal tunable filter for this work, which enables a continuously tunable, narrow band-pass transmission wavelength 14 . The primary advantage of this is that it enables quantitative separation of multiple sources of contrast using chemometric algorithms 23 . We focus here on two primary sources of contrast: hemoglobin absorption, which enables quantification of total hemoglobin concentration and oxygen saturation; and quantitative spectral decomposition and extraction of fluorophore distribution.
MaterIals

REAGENTS
Surgery:
Mice . 1 ).
Custom-machined C-holder (C-holder for 12-mm window chamber unit, Research Instruments) Custom-machined Plexiglas viewing stage (see •
• design the imaging mount such that the window will remain fixed in place to avoid motion artifacts. Imaging mount (custom made) (see Fig. 3 and EQUIPMENT SETUP ).  crItIcal Xylazine is not metabolized as rapidly as ketamine, so redosing is generally performed with ketamine only. This need not be prepared fresh, and can be stored for several weeks at room temperature. Buprenophine solution. Dilute the stock buprenophine solution to 15 mg ml − 1 in sterile 0.9% (wt/vol) NaCl solution. This need not be prepared fresh, and can be stored for several weeks at room temperature. Tumor cell suspension. Suspend the cultured cells in appropriate phenol red-free culture medium at a concentration such that a 20-µl volume contains the desired number of cells for inoculation. The cell suspension should be used on the same day as the preparation. EQUIPMENT SETUP Surgical station Window chamber surgeries must be performed using aseptic technique to minimize the risk of animal infection. A laminar flow HEPA-filtered hood or other flow-isolated environment with an accessible electrical outlet is an ideal location. Within the station, position the fiber optic lamp such that the lamp output is at the appropriate height and angle to with an open bottom and back-the crucial design characteristics are that it is sufficiently large to hold the wax heating pad, and that it provides a sturdy platform for the surgery. Sterilization wrap squares Cut a piece of 40-inch × 40-inch sterilization wrap into ~6-inch squares. Fold the squares diagonally and make a 3-4 cm slit along the diagonal.
Surgical kit preparation
The following items must be sterilized before surgery: window chamber units, C-holder, glass microsyringe, mayo scissors, iris scissors, conjunctival scissors, jeweler-type forceps, mosquito forceps, needle driver, nut driver, cotton gauze, viewing stage, leather hole puncher, binder clips, ring pliers, nut driver, sterilization wrap squares and Petri dish. Place all items that can be safely steam-sterilized into the surgical tray and wrap it in sterilization wrap. Autoclave the kit for at least 90 min at 121 °C. Separately pack and gas-sterilize any items that can rust or melt. Surgical station preparation Immediately before surgery, thoroughly wipe down all surfaces within the working station with Sporicidin. Place the surgical kit in the middle of the working area and carefully unwrap it without touching the kit itself or the sterile inner surface of the sterilization wrap. The sterilization wrap should now provide a broad sterile surface on which to work. Reach in beneath the sterilization wrap and position the surgical kit to one side of the sterile working area. Using sterile technique, drop the rest of the gas-sterilized and sterile prepackaged equipment into the surgical tray.
Heat the paraffin pad in a microwave for a few minutes on the highest power setting until the wax is partially melted. Place the paraffin pad in the middle of the sterile working area. Thoroughly wipe down the surgical platform with Sporicidin and place it on top of the paraffin pad. (Although the paraffin pad and the surgical platform are not sterile, these will be covered with the sterile field at a later point.) Place the sterile Petri dish on the hot pad without touching the inner surface, and fill it with ~10 ml of sterile saline. Heat the saline to ~37 °C. Animal housing Mice can be housed under standard conditions, ensuring that there is enough clearance for them to move freely in the cage after the window is implanted. A standard rat cage is often convenient for this purpose. Make sure to add sufficient bedding so that the mice can reach their food and water. Imaging mount The imaging mount can be custom machined to suit the imaging setup. The simplest configuration is a stiff metal or plastic sheet with four holes drilled in it, a central 12-mm-diameter hole for imaging, and three surrounding holes through which the window chamber bolts can pass (~2 mm diameter). An extra set of nuts can then be screwed into the bolt to securely affix the window chamber to the imaging bracket, and the bracket itself can be designed such that it can be securely attached to the microscope stage.
proceDure Dorsal window chamber surgery • tIMInG 30 min 1| Anesthetize the mouse by intraperitoneal injection of the ketamine/xylazine working solution, corresponding to doses ranging from 85-100 mg kg − 1 ketamine and 8.5-10 mg kg − 1 xylazine. Place the mouse on a thermostatic blanket in a sternally recumbent position to maintain a body temperature of ~37 °C.  crItIcal step The mouse should be monitored carefully throughout the surgery for response to any physical stimuli during the procedure and redosed appropriately using 25-33% of the initial dose of ketamine only. ? trouBlesHootInG 2| Apply artificial tear ointment to the mouse's eyes.  crItIcal step Failure to keep the eyes adequately hydrated can lead to corneal desiccation and permanent eye injury.
3|
For surgeries on hairless mice, proceed directly to Step 4. For surgeries on hirsute mice, shear the dorsal area from nape to tail along the back and to the midline of the limbs on either side using an electric shaver. Apply hair removal lotion to the shorn area and remove hair remnants according to the product instructions, usually after ~5 min.  crItIcal step Product instructions and veterinary guidance must be followed carefully; if the lotion is left on for too long, it can cause skin irritation or injury.
4|
Apply chlorhexidine solution to the dorsal region of the mouse's torso and the entire tail with cotton gauze. After thorough application, immediately remove the chlorhexidine with cotton gauze soaked in 70% (vol/vol) ethanol. Repeat this process two more times.
5| Don surgical gear.  crItIcal step From this point forward, sterile technique should be followed in order to minimize the risk of infection. Do not allow gloved hands or sterile equipment to come into contact with nonsterile objects, including any portion of the mouse not treated with chlorhexidine.
6|
Within the surgical area, attach the Plexiglas viewing stage to the surgical platform with the metal binder clips. Cut a rectangular hole in the sterile field so that the viewing stage is exposed through the hole, but the sterile field completely covers the surgical platform (Fig. 4) .
7|
Mark the mouse along the length of the spine with the surgical marker. At the peak of the back, apply two small dots on either side of the line, ~5 mm apart. This will establish a landmark for proper window chamber placement (Fig. 5) . 8| Drape one of the sterilization wrap squares over the mouse with the slit aligned with the line drawn along the length of the spine. Roll up and secure the loose corners of the square with a paper clip. Take care to handle only the outer side of the sterilization wrap.
9|
Transfer the mouse to the sterile working area.
10| Gently pull the loose dorsal skin through the slit and secure it to the C-holder with four stitches made along the back-line such that the skin fans out with enough working area to accommodate the window chamber (Fig. 6) . For portions of the surgery that require delicate manipulation, the C-holder can be hung from the viewing stage for better visibility. ? trouBlesHootInG 11| Hold the flat side of one of the window chamber pieces against the skin fold such that the dot that was drawn on the back is aligned with the top screw hold of the window chamber. Mark the positions of the other screw holes and trace the circumference of the window area with the surgical marker.
12| Punch a hole through both sides of the skin at each of the screw locations using either the hole puncher or a 16G needle.
13|
Using the mosquito forceps to hold the skin and cutting along the circumference of the drawn circle with the iris scissors, remove the forward-facing portion of skin, leaving the opposing layer intact.
14|
Periodically flush the exposed dermis with warm saline (prewarmed to 37 °C) throughout the remainder of the surgery to clear away blood and keep the dermis hydrated. ? trouBlesHootInG 15| Using the jeweler forceps and the conjunctival scissors, remove any remaining loose connective tissue, leaving intact the fine, translucent fascial plane that covers the dermis.
16|
Insert the screws on the front window chamber frame through the three smaller holes, cutting away any obstructing connective tissue with the conjunctival scissors.
17|
Use the nuts to fasten the rear frame to the front frame, manipulating the skin to keep the exposed dermis centered within the frame.  crItIcal step To avoid infection, the frame must be secured tightly enough to ensure that the wound is fully sealed by the window chamber frame. Avoid over-tightening the frame, however, as this may inhibit circulation and lead to necrosis. The dots will be used to ensure that the window chamber is sutured at the proper height and lateral position on the torso.
18|
Using the microsyringe, and holding the needle tip at a shallow angle with the bevel up, inject ~20 µl of the vortexed tumor-cell suspension between the exposed fascial plane and the dermis. A small bubble should be visible (Fig. 7) .  crItIcal step The cell suspension must be injected beneath the fascia to achieve tumor growth. Avoid injection into or damage to the dermal tissue, as this may cause wound lesions that visually obscure the tumor. If necessary, the fascia can be lightly lifted with the jeweler forceps to better facilitate proper injection.
? trouBlesHootInG
19|
While holding it level, fill the window with warm saline until a meniscus forms.
20|
Place the glass cover slip over the window with the jeweler forceps. Push the cover slip down into position, allowing the saline to leak out around the edges. Ensure that no air bubbles remain within the sealed window.
21| Secure the cover slip with a retaining ring.
22|
With the skin taut, suture the window chamber to the skin using the small holes along the edge of the frame.
23|
Use the surgical blade to remove the sutures attaching the skin to the C-holder.
24|
Return the mouse to the thermostatic blanket for recovery, and remove the sterile wrapping. Apply antibiotic ointment to the suture wounds. As the mouse begins to regain mobility, subcutaneously inject 0.05-0.15 mg kg − 1 of buprenorphine solution for pain management. ? trouBlesHootInG 25| If you are performing further surgeries, wipe down and resterilize the contaminated portions of the surgical tools with the glass-bead sterilizer, and ensure that the paraffin heating pad is still warm. recovery and tumor growth • tIMInG 5-10 d 26| Return the mouse to the animal housing facility after it has fully recovered from anesthesia. Tumor growth should be visually apparent within 5-10 d, although this may vary depending on the cell line and mouse strain. Postoperative monitoring should include checking for excessive weight loss, posture, activity level or facial expression. Humane endpoints should be approved by the appropriate regulatory body and generally should include excessive weight loss ( >15%) and unresolved infection or pain.  crItIcal step Some tumor lines grow best in a warm environment. If tumor growth is not apparent after several surgeries, the animals may be housed in an environmental chamber with an elevated temperature and humidity (34 °C with 50% humidity). This ensures that the window chamber tissue remains warm and moist. ? trouBlesHootInG 
27|
Readminister buprenorphine 8-12 h after surgery, and then as needed for pain alleviation. Generally, the animals should recover fully from surgery and anesthesia and show no signs of distress by the next day.  crItIcal step Examine the mice daily for signs of distress, adhering to appropriate institutional and governmental guidelines for pain management and humane endpoints.
Imaging setup • tIMInG 30 min 28|
Turn on fluorescence and white-light sources, camera, tunable filter and heating pad, and allow the instruments to warm up for the recommended time period (15-30 min).
29|
Anesthetize the mouse by positioning a nose cone over the snout while physically restraining it, or by placing the mouse in an induction chamber with 2.5% (vol/vol) isoflurane.  crItIcal step All animal experiments related to imaging should comply with relevant institutional and national animal care guidelines.
30|
When the animal is unconscious (after ~60 s of isoflurane inhalation), transfer it to the heated pad on the microscope stage and reduce the isoflurane dose to 1% (vol/vol).  crItIcal step Continuously monitor the mouse's depth of anesthesia by noting the breathing rate, toe pinch reflex and twitching; adjust the isoflurane dose as needed between 1 and 2.5% (vol/vol). Anesthesia must be maintained at an appropriate depth and carefully monitored to avoid adversely affecting respiration while still minimizing motion artifacts.
31|
Apply moisturizing ointment to the eyes.  crItIcal step The mouse will not blink while anesthetized; eye dehydration can cause permanent damage.
32|
Clean the glass window with a cotton swab soaked in alcohol.
33|
Affix the window frame to the imaging mount and position it on the imaging stage.
Imaging • tIMInG 5-10 min per mouse 34| Carry out bright-field imaging as described in option A or fluorescence imaging as described in option B. Fluorescence imaging can be performed independently, or in the same animal as bright-field imaging. It is also possible to sequentially switch between bright-field and fluorescence imaging.
(a) Bright-field imaging (absorption contrast, hemoglobin oxygen saturation) (i) Select the desired magnification, adjust the focus and identify the region(s) to be imaged.
(ii) Acquire images in 10-nm increments from 520-620 nm; the critical region of the spectrum includes 550-600 nm, where the major structures of the oxygenated and deoxygenated hemoglobin absorption spectra are present.  crItIcal step The exposure time should be adjusted such that there are no saturated pixels in any of the images for the region of interest, and that there is a sufficiently high signal-to-noise ratio. This often requires fine-tuning of the exposure times for each wavelength at the start of each session. (iii) Acquire image sequences as frequently as required to characterize fluctuations in oxygenation (which typically occur with a dominant period of 10-20 min). A frequency of approximately once every 3 min is generally adequate. (iv) Perform image calibration to correct for the effects of different exposure times and to eliminate signal contributions from the camera's dark offset. The dark offset is measured by blocking the light source and acquiring an image.  crItIcal step Cameras will commonly have an offset parameter, and it is important to set this value such that there is a small positive offset in a dark image. Otherwise, it is impossible to correctly calibrate for dark offset. Other camera settings (gain, postacquisition correction factors and so on) should ideally be held constant for all images.
To correct for system response, we have used an absolute calibration scheme, whereby the system throughput is characterized using neutral density (ND) filters that are placed in the light path of the microscope. This enables measurement of the system response function without saturating the detector. Absorptive ND filters with an optical density (OD) ranging from 0.5 to 3 are used for this purpose. An ND filter is selected such that the same imaging parameters used to measure tissue transmission can be used to measure the system throughput. The entire spectrum is acquired using settings identical to those used for tissue imaging, with the appropriate ND filter in place. (ii) Select the desired magnification, adjust the focus and identify the region to be imaged. The focus can be adjusted using the bright-field image if the fluorescence is dim or does not show clear structure. (iii) Inject the fluorophore (if using an extrinsic probe). If you are injecting directly onto/into the window chamber tissue, this can be done either topically by removing the window, or by injecting through the skin behind the window. (iv) Collect a sequence of images spanning the emission range of the fluorophore of interest. Adjust the camera settings at the start of each session to obtain ideal images while taking care not to saturate the signal. (v) Acquire the calibration images. A dark offset image should be acquired as described in Step 34A(iv). This is a crucial step in the accurate modeling of spectral components. A reference slide can also be used to calibrate overall system throughput, which is used to compare absolute intensity changes from day to day. (vi) Process data as described in Box 2.
Box 1 | BRIGHT-FIELD DATA PRoCESSING • tIMInG VARIABLE
Image processing can be achieved using the algorithms referenced here and in Box 2. There are several commercial and open-source image-processing applications that are suitable for this work, including MATLAB (http://www.mathworks.com) and Python (http://python.org and http://www.scipy.org). 1. The calibrated image can be expressed as
where I cal is the calibrated image, I raw is the raw measure data, I dark is the dark image and t exposure is the exposure time.
2. This enables calculation of the absolute attenuation of light in the tissue by the following equation:
where A is the tissue attenuation, I cal_tissue is the calibrated tissue image, I cal_ND is the calibrated ND image and OD is the OD of the filter used. 3. Because these data are acquired at discrete wavelength bands, A can be expressed as a function of wavelength-dependent attenuation factors. Using a modified version of Beer's law to account for the effects of scattering, this can be expressed as follows:
where b 0 is a constant term accounting for overall changes in signal due to source intensity, spectral reflection and so on. µ eff is the effective attenuation coefficient derived from diffusion theory 25 ,
calculated for representative skin optical properties at each wavelength 26 ; it accounts for attenuation due to nonhemoglobin absorption and scattering, with b 1 being a free parameter modulating the magnitude of this term. ε i (λ) gives the extinction coefficient of the i th absorber as a function of wavelength accounted for explicitly in the model. In this case, oxygenated and deoxygenated hemoglobin are generally used, but it is also possible to include other terms, such as methemoglobin, for example. A linear non-negative least squares fitting algorithm is used to extract the terms b 0 , b 1 and C i , on a pixel-by-pixel basis. In this case, C i is a composite term that is effectively the product of the concentration and path length of light attenuated by each absorber. This enables quantification of the relative total hemoglobin (Hb) content × path length product as C deoxyHb + C oxyHb , where these correspond to deoxygenated Hb and oxygenated Hb, respectively. The hemoglobin oxygen saturation is calculated as C oxyHb / (C deoxyHb + C oxyHb ) × 100%. In this case the path length term cancels out. 4. To exclude pixels for which the model does not adequately fit the data, an R 2 threshold can be used, for example, by excluding all pixels with an R 2 threshold <0.9. Generally, most pixels will have an R 2 value greater than this, but this is also useful as a diagnostic check to ensure that all processing and calibration were done correctly. 5. We have used several methods to visualize the data; one method is to simply display each parameter individually on a pseudocolor scale. It is also possible to combine the data such that the hemoglobin oxygen saturation is plotted on a pseudocolor scale, the intensity of which is modulated by the total hemoglobin × path length parameter. This highlights regions of large vessels or high vessel density, such as in tumors, where there is a large hemoglobin signature (see ANTICIPATED RESULTS).
? trouBlesHootInG Troubleshooting advice can be found in table 1.
Box 2 | FLUoRESCENCE IMAGE ANALYSIS • tIMInG VARIABLE
Image processing can be achieved using the algorithms referenced here and in Box 1. There are several commercial and open-source image-processing applications that are suitable for this work, including MATLAB (http://www.mathworks.com) and Python (http://python.org and http://www.scipy.org). 1. The fluorescence images can be calibrated for exposure time and dark offset as described above (Box 1, Step 1).
? trouBlesHootInG 2. Emission spectra can be modeled as a linear combination of all sources of fluorescence within the sample. This will typically include autofluorescence, as well as the extrinsic sources of fluorescence, or genetically encoded fluorophores (e.g., GFP). We have thus used a PARAFAC algorithm to decompose tissue spectra into constituent spectra 23 . This algorithm would ideally be fed spectral data from all treatment groups used in an experiment. It will then attempt to optimize the component spectra and relative contributions pixel by pixel to minimize the sum-of-squares error between the measured and modeled spectra. The outputs are the constitutive spectra. A linear combination of these derived spectra represents the raw measured spectrum. This method is most useful for the case in which there are multiple overlapping fluorophores (such as with many ratiometric probes) or in cases in which tissue autofluorescence is significant. We have previously used this approach with a ratiometric oxygen sensor 24 . 3. The variable parameters specified in this model include the non-negativity constraint, which is applied to all spectra and component weightings. The model also requires the user to specify the number of spectral components. This needs to be determined based on the goodness of fit and a priori knowledge of the constitutive fluorophores present. 4. Data visualization can be done by displaying the component weightings. Using the spectrum of each component and the relative distribution, it is possible to determine which fluorophore each component corresponds to. For the case in which only a single fluorophore is present and the background autofluorescence is minimal, the calibrated intensity (from Step 1 of this box) is often an adequate measure of fluorescence intensity. Step 34A, Bright-field imaging: 5-10 min Box 1, Bright-field data processing: variable (Data processing can be performed at any time after images are collected.
Computational processing time depends upon the speed of the computer system and the total size of the data set.)
Step 34B, fluorescence imaging: 5-10 min Box 2, Fluorescence image analysis: variable (see bright-field data processing)
antIcIpateD results
Typical results are shown in Figure 8 . This image was acquired from a window chamber implanted with a 4T1 mammary carcinoma cell line that expresses GFP driven by an hypoxia inducible factor (HIF)-1 promoter 12 . Thus, the GFP signal is reflective of HIF-1 activity. Both fluorescence and transmission images were acquired, enabling characterization of both There may be variability in skin thickness among mice, and some window chamber designs may restrict blood circulation due to insufficient space between the frames. This may be corrected by changing the size of the spacers separating the window chamber frames. This can be tested immediately after surgery by verifying that the skin is free to move slightly around the window Box 2 Poor separation of sources of fluorescence
Adjustment of PARAFAC parameters is needed
In order to effectively separate multiple sources of fluorescence, the correct number of components needs to be specified, and then data must be correctly calibrated. The number of components should be increased until additional components do not characterize additional sources of contrast (i.e., they will appear as noise). Alternatively, when a priori information about the fluorescence emission spectra is available or pure signal from only a single fluorophore can be obtained, directly use the known spectra of each fluorophore in the tissue protocol nature protocols | VOL.6 NO.9 | 2011 | 1365 hemoglobin absorption and GFP. This enables characterization of vascular oxygenation as well as HIF-1 activity simultaneously. Furthermore, transmitted images in the visible spectral band (where vessels are distinct because of hemoglobin's high optical absorption coefficients) can be quantitatively analyzed for parameters of vascular structure (e.g., vascular length density, vessel diameter, tortuosity) using scientific image processing software. Figure 9 shows results of using the Parallel factor analysis (PARAFAC) 23 algorithm to decompose overlapping spectra. In this case, an oxygen-sensing boron nanoparticle having stable blue fluorescence emission and oxygen-quenched green fluorescence was imaged sequentially in 5-nm wavelength intervals from 425 to 575 nm using the hyperspectral imaging system previously described 13 . As the fluorescence is independent of oxygen concentration, it provides a stable control against which to normalize the phosphorescence signal. Thus, the ratio of the fluorescence and phosphorescence intensities is capable of directly reporting oxygen tension. In this case, a solution of 1 mg ml − 1 boron nanoparticles was topically applied and imaged (as described above) under bright-field trans-illumination. The bright-field image (Fig. 9a) shows the highly vascularized tumor on the left-hand side of the image. The raw fluorescence averaged across all wavelengths is seen in Figure 9b , which represents the integrated intensity of the nanoparticles. The total emission spectrum extracted from an averaged pixel sample was decomposed using PARAFAC into constituent fluorescence and phosphorescence spectra (Fig. 9c) , with the component scores shown (Fig. 9d,e) . Only after normalizing the fluorescence/phosphorescence image can the oxygen distribution be seen (Fig. 9f) , which can then be calibrated to provide absolute oxygen tension 24 . 
